Medicare Enrolled
Dr. Yale Cohen, MD
Cardiovascular Disease · Hollywood, FL
Practice pattern: Remote Monitoring— Significant remote device monitoring activity
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cohen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cohen? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cohen
Dr. Yale Cohen is a cardiovascular disease in Hollywood, FL, with 19 years in practice. Based on federal Medicare data, Dr. Cohen performed 23,211 Medicare services across 5,106 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cohen received a total of $60,165 from 69 pharmaceutical and/or device companies across 827 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cohen is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 1% volume in FL$ $60,165 industry payments
Medicare Practice Summary
Medicare Utilization ↗23,211
Medicare services
Top 1% in FL for cardiovascular disease
5,106
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,222 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 8,141 | $0 | $1 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 2,827 | $32 | $129 |
| Remote patient monitoring management, 20 min/month | 2,309 | $38 | $159 |
| Remote patient monitoring device, 30 days | 1,872 | $36 | $189 |
| Office visit, established patient (30-39 min) | 1,174 | $95 | $300 |
| Hospital follow-up visit, moderate complexity | 1,142 | $65 | $200 |
| Hospital follow-up visit, high complexity | 814 | $97 | $275 |
| Electrocardiogram (EKG), 12-lead | 793 | $11 | $75 |
| EKG interpretation and report | 449 | $7 | $9 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 394 | $88 | $120 |
| Echocardiogram, transthoracic | 343 | $138 | $600 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 330 | $30 | $111 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 324 | $226 | $1,052 |
| Initial hospital admission, high complexity | 217 | $140 | $550 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 198 | $21 | $120 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 183 | $49 | $400 |
| Remote pacemaker/defibrillator monitoring, 90 days | 148 | $18 | $150 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 146 | $21 | $120 |
| Ultrasound of both sides of head and neck blood flow | 138 | $135 | $900 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 127 | $11 | $125 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 114 | $21 | $100 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 113 | $652 | $2,500 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 107 | $131 | $625 |
| Remote pacemaker monitoring, 90 days | 91 | $24 | $150 |
| Ultrasound of aorta, vena cava, groin vessels or bypass grafts | 74 | $79 | $450 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 62 | $16 | $60 |
| Ultrasound of leg arteries or artery grafts | 60 | $178 | $1,000 |
| Test for exercise-induced lung stress | 59 | $26 | $135 |
| New patient office visit (45-59 min) | 59 | $118 | $500 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 58 | $29 | $250 |
| Transitional care management services for problem of high complexity | 55 | $219 | $850 |
| Initial hospital admission, moderate complexity | 53 | $104 | $400 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 46 | $1,352 | $7,500 |
| Laser destruction of incompetent vein of arm or leg using imaging guidance | 34 | $805 | $5,000 |
| Office visit, established patient, complex (40-54 min) | 33 | $145 | $425 |
| Ambulatory blood pressure monitoring, 1 day or longer, with recording, scanning analysis, interpretation, and report | 21 | $32 | $250 |
| Transitional care management services for problem of at least moderate complexity | 18 | $156 | $600 |
| Ultrasound of heart | 16 | $35 | $244 |
| Smoking and tobacco use intensive counseling, more than 10 minutes | 15 | $28 | $90 |
| Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles | 14 | $171 | $950 |
| Test to measure exhaled air for evaluation of lung function during rest and exercise | 14 | $43 | $75 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 13 | $17 | $125 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) | 13 | $22 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.1% high complexity
39.7% medium
57.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$60,165
Total received (2018-2024)
Avg $8,595/year across 7 years
Top 7% in FL for cardiovascular disease
69
Companies
827
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$28,951 (48.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,132 (35.1%)
Other
Charitable contributions, space rental, and other categories
$8,737 (14.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,344 (2.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$11,112
2023$10,024
2022$8,529
2021$12,023
2020$8,254
2019$5,929
2018$4,293
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$24,770
AngioDynamics, Inc.
$8,940
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$4,412
Medtronic Vascular, Inc.
$2,622
Abbott Laboratories
$2,524
NOVARTIS PHARMACEUTICALS CORPORATION
$2,237
Boston Scientific Corporation
$2,055
Medtronic, Inc.
$2,021
Novartis Pharmaceuticals Corporation
$1,557
Janssen Pharmaceuticals, Inc
$1,112
E.R. Squibb & Sons, L.L.C.
$858
Amgen Inc.
$685
PFIZER INC.
$678
SANOFI-AVENTIS U.S. LLC
$455
Bard Peripheral Vascular, Inc.
$412
Impulse Dynamics (USA) Inc.
$393
BIOTRONIK INC.
$388
Alnylam Pharmaceuticals Inc.
$290
Merck Sharp & Dohme LLC
$288
Boehringer Ingelheim Pharmaceuticals, Inc.
$278
Terumo Medical Corporation
$255
Cardiovascular Systems Inc.
$235
Amarin Pharma Inc.
$184
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$180
CVRx, Inc.
$148
Philips Electronics North America Corporation
$148
HeartFlow, Inc.
$142
BOSTON SCIENTIFIC CORPORATION
$138
Merck Sharp & Dohme Corporation
$121
ShockWave Medical, Inc
$112
MicroPort CRM USA Inc
$106
Shockwave Medical, Inc
$88
Venclose Inc.
$87
Penumbra, Inc.
$70
Vital Connect, Inc
$69
Itamar Medical Inc
$65
Lilly USA, LLC
$62
Kiniksa Pharmaceuticals, Ltd.
$58
Actelion Pharmaceuticals US, Inc.
$53
Lexicon Pharmaceuticals, Inc.
$52
Otsuka America Pharmaceutical, Inc.
$49
Esperion Therapeutics, Inc.
$47
Inari Medical, Inc.
$46
Novo Nordisk Inc
$43
Biocompatibles, Inc.
$42
Philips North America LLC
$42
GlaxoSmithKline, LLC.
$42
Akcea Therapeutics, Inc.
$42
Exact Sciences Corporation
$42
Bayer HealthCare Pharmaceuticals Inc.
$40
Cook Medical LLC
$36
Regeneron Healthcare Solutions, Inc.
$32
Kowa Pharmaceuticals America, Inc.
$30
Astellas Pharma US Inc
$29
Kiniksa Pharmaceuticals International, plc
$23
ARBOR PHARMACEUTICALS, INC.
$21
ABIOMED
$21
Bardy Diagnostics, Inc.
$20
MEDICOMP INC
$19
SCPHARMACEUTICALS INC.
$19
W. L. Gore & Associates, Inc.
$18
Bayer Healthcare Pharmaceuticals Inc.
$17
BARD PERIPHERAL VASCULAR, INC.
$15
Tactile Systems Technology Inc
$15
Medicure Pharma Inc.
$14
Edwards Lifesciences Corporation
$14
Nuwellis, Inc.
$14
Becton, Dickinson and Company
$14
PORTOLA PHARMACEUTICALS, LLC
$12
Top 3 companies account for 63.4% of total payments
Associated products mentioned in payments ›
(5091) Amb Mon & Diag Und · (9285) AngioSculpt PV · (DD1) Duo Hybrid · AMPLATZER AMULET · ANDEXXA · ANGIO-SEAL · AURYON LASER SYSTEM 100-120 VAC · AVEIR · AVVIGO Guidance System · AZURE XT DR MRI SURESCAN · Amplia MRI · Aquadex Smartflow Console · Arcalyst · Azure · BELSOMRA · BIOMONITOR · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · CLOSUREFAST · CLOSURERFS · CONFIRM RX · CRM Product · Cardiac Monitor · Carnation Ambulatory Monitor · Claria MRI · ClosureFast · Cologuard Collection Kit · Confirm Rx · Corlanor · Coronary Orbital Atherectomy System · DIAMONDBACK CORONARY · DIAMONDBACK PERIPHERAL · Diamondback Coronary · Diamondback Peripheral · ELIQUIS · ENTRESTO · EVENITY · EVRSF · Edarbi · Edarbyclor · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FFRct · FLOWTRIEVER CATHETER · FUROSCIX · Flexitouch Plus · GALLANT · GENERAL - VASCULAR INTERVENTION · GENERAL PAIN MANAGEMENT · GLIDEWIRE · GORE CARDIOFORM Septal Occluder · Glidesheath · HEARTRAIL · IGT_D Coronary · Impella · Indigo · Indigo System · Inpefa · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LINQ II · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · METACROSS OTW · MICRA · MULTAQ · MYCARELINK · Merlin Connectivity and Remote · Micra · NAVICROSS · NEXLETOL · ONPATTRO · OPSUMIT · OPTIMIZER · Optimizer Smart System · Optitorque · Ozempic · PRADAXA · PRALUENT · Peripheral Orbital Atherectomy System · Quadra Assura CRT Defibrillator · ROTAPRO · Repatha · Reveal LINQ · S · SAMSCA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SelectSecure · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Solia · TEGSEDI · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · VARITHENA · VENACURE 1470 PRO · VENASEAL · VENOVO · VERQUVO · VITALPATCH RTM · VYNDAMAX · VYNDAQEL · Varithena Administration Pack · Vascepa · Vascular Lithotripsy · VenaCure 1470 Pro · VenaSeal · Venclose Maven Catheter · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WatchPATONE · XARELTO · XIFAXAN · Zilver PTX · Zypitamag
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (48%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for cardiovascular disease in FL.
Equivalent to $259 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
463
Per 100K population
23.8
County median income
$74,534
Nearest hospital
MEMORIAL REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Cohen is a remote monitoring specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (speaking/promotional, top 7%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Cohen experienced with injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)?
Based on Medicare claims data, Dr. Cohen performed 8,141 injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cohen receive payments from pharmaceutical companies?
Yes. Dr. Cohen received a total of $60,165 from 69 companies across 827 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cohen's costs compare to other cardiovascular diseases in Hollywood?
Dr. Cohen's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cohen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Hollywood
Browse cardiovascular diseases in Hollywood ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
AngioDynamics, Inc. Payments to Doctors
See all physicians who received payments from AngioDynamics, Inc..
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology